Recently, there have been some studies on liquid biopsy to assess the status of the systemic immune system and predict the therapeutic effect of ICI for UTUC, such as the neutrophil-to-lymphocyte ratio and fibroblast growth factor receptor 3 [12,13]. Here, FGFR3 is linked to renal pelvis/ureter urothelial carcinoma.